These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 16777413)

  • 21. Structure-activity relationship studies on a series of cyclohexylpiperazines bearing a phanylacetamide as ligands of the human melanocortin-4 receptor.
    Pontillo J; Tran JA; White NS; Arellano M; Fleck BA; Marinkovic D; Tucci FC; Saunders J; Foster AC; Chen C
    Bioorg Med Chem Lett; 2005 Dec; 15(23):5237-40. PubMed ID: 16183282
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Studies on the structure-activity relationship of the basic amine of phenylpiperazines as melanocortin-4 receptor antagonists.
    Tran JA; Arellano M; Fleck BA; Pontillo J; Marinkovic D; Tucci FC; Wen J; Saunders J; Chen C
    Med Chem; 2008 Jan; 4(1):67-74. PubMed ID: 18220971
    [TBL] [Abstract][Full Text] [Related]  

  • 23. 4-{(2R)-[3-Aminopropionylamido]-3-(2,4-dichlorophenyl)propionyl}-1-{2-[(2-thienyl)ethylaminomethyl]phenyl}piperazine as a potent and selective melanocortin-4 receptor antagonist--design, synthesis, and characterization.
    Chen C; Pontillo J; Fleck BA; Gao Y; Wen J; Tran JA; Tucci FC; Marinkovic D; Foster AC; Saunders J
    J Med Chem; 2004 Dec; 47(27):6821-30. PubMed ID: 15615531
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A potent and selective nonpeptide antagonist of the melanocortin-4 receptor induces food intake in satiated mice.
    Pontillo J; Tran JA; Markison S; Joppa M; Fleck BA; Marinkovic D; Arellano M; Tucci FC; Lanier M; Nelson J; Saunders J; Hoare SR; Foster AC; Chen C
    Bioorg Med Chem Lett; 2005 May; 15(10):2541-6. PubMed ID: 15863313
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Melanocortin subtype-4 receptor agonists containing a piperazine core with substituted aryl sulfonamides.
    Fotsch C; Han N; Arasasingham P; Bo Y; Carmouche M; Chen N; Davis J; Goldberg MH; Hale C; Hsieh FY; Kelly MG; Liu Q; Norman MH; Smith DM; Stec M; Tamayo N; Xi N; Xu S; Bannon AW; Baumgartner JW
    Bioorg Med Chem Lett; 2005 Mar; 15(6):1623-7. PubMed ID: 15745810
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Privileged structure based ligands for melanocortin receptors--4,4-disubstituted piperidine derivatives.
    Kuklish SL; Backer RT; Briner K; Doecke CW; Husain S; Mullaney JT; Ornstein PL; Zgombick JM; O'Brien TP; Fisher MJ
    Bioorg Med Chem Lett; 2006 Jul; 16(14):3843-6. PubMed ID: 16697186
    [TBL] [Abstract][Full Text] [Related]  

  • 27. 2-Piperazinecarboxamides as potent and selective melanocortin subtype-4 receptor agonists.
    Palucki BL; Park MK; Nargund RP; Tang R; MacNeil T; Weinberg DH; Vongs A; Rosenblum CI; Doss GA; Miller RR; Stearns RA; Peng Q; Tamvakopoulos C; Van der Ploeg LH; Patchett AA
    Bioorg Med Chem Lett; 2005 Apr; 15(8):1993-6. PubMed ID: 15808454
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Optimization of privileged structures for selective and potent melanocortin subtype-4 receptor ligands.
    Hong Q; Bakshi RK; Dellureficio J; He S; Ye Z; Dobbelaar PH; Sebhat IK; Guo L; Liu J; Jian T; Tang R; Kalyani RN; Macneil T; Vongs A; Rosenblum CI; Weinberg DH; Peng Q; Tamvakopoulos C; Miller RR; Stearns RA; Cashen D; Martin WJ; Chen AS; Metzger JM; Chen HY; Strack AM; Fong TM; Maclntyre E; Van der Ploeg LH; Wyvratt MJ; Nargund RP
    Bioorg Med Chem Lett; 2010 Aug; 20(15):4483-6. PubMed ID: 20598533
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Structure-activity relationship studies on a series of piperazinebenzylalcohols and their ketone and amine analogs as melanocortin-4 receptor ligands.
    Marinkovic D; Tucci FC; Tran JA; Fleck BA; Wen J; Chen C
    Bioorg Med Chem Lett; 2008 Sep; 18(17):4817-22. PubMed ID: 18682322
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Structure-activity relationship of a series of cyclohexylpiperidines bearing an amide side chain as antagonists of the human melanocortin-4 receptor.
    Tran JA; Pontillo J; Arellano M; Fleck BA; Tucci FC; Marinkovic D; Chen CW; Saunders J; Foster AC; Chen C
    Bioorg Med Chem Lett; 2005 Jul; 15(14):3434-8. PubMed ID: 15950470
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Identification and structure-activity relationships of a new series of Melanocortin-4 receptor antagonists.
    Vos TJ; Balani S; Blackburn C; Chau RW; Danca MD; Drabic SV; Farrer CA; Patane MA; Stroud SG; Yowe DL; Claiborne CF
    Bioorg Med Chem Lett; 2006 Apr; 16(8):2302-5. PubMed ID: 16458508
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Identification of a novel series of benzimidazoles as potent and selective antagonists of the human melanocortin-4 receptor.
    Poitout L; Brault V; Sackur C; Bernetière S; Camara J; Plas P; Roubert P
    Bioorg Med Chem Lett; 2007 Aug; 17(16):4464-70. PubMed ID: 17574418
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Discovery of (2S)-N-[(1R)-2-[4-cyclohexyl-4-[[(1,1-dimethylethyl)amino]carbonyl]-1-piperidinyl]-1-[(4-fluorophenyl)methyl]-2-oxoethyl]-4-methyl-2-piperazinecarboxamide (MB243), a potent and selective melanocortin subtype-4 receptor agonist.
    Palucki BL; Park MK; Nargund RP; Ye Z; Sebhat IK; Pollard PG; Kalyani RN; Tang R; Macneil T; Weinberg DH; Vongs A; Rosenblum CI; Doss GA; Miller RR; Stearns RA; Peng Q; Tamvakopoulos C; McGowan E; Martin WJ; Metzger JM; Shepherd CA; Strack AM; Macintyre DE; Van der Ploeg LH; Patchett AA
    Bioorg Med Chem Lett; 2005 Jan; 15(1):171-5. PubMed ID: 15582434
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Discovery of a piperazine urea based compound as a potent, selective, orally bioavailable melanocortin subtype-4 receptor partial agonist.
    Hong Q; Bakshi RK; Palucki BL; Park MK; Ye Z; He S; Pollard PG; Sebhat IK; Liu J; Guo L; Cashen DE; Martin WJ; Weinberg DH; MacNeil T; Tang R; Tamvakopoulos C; Peng Q; Miller RR; Stearns RA; Chen HY; Chen AS; Strack AM; Fong TM; MacIntyre DE; Wyvratt MJ; Nargund RP
    Bioorg Med Chem Lett; 2011 Apr; 21(8):2330-4. PubMed ID: 21439820
    [TBL] [Abstract][Full Text] [Related]  

  • 35. MC4 receptor antagonists: a potential treatment for cachexia.
    Foster AC; Chen C; Markison S; Marks DL
    IDrugs; 2005 Apr; 8(4):314-9. PubMed ID: 15800806
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The discovery of potent antagonists of NPBWR1 (GPR7).
    Anthony Romero F; Hastings NB; Moningka R; Guo Z; Wang M; Di Salvo J; Lei Y; Trusca D; Deng Q; Tong V; Terebetski JL; Ball RG; Ujjainwalla F
    Bioorg Med Chem Lett; 2012 Jan; 22(2):1014-8. PubMed ID: 22197390
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Identification and characterization of pyrrolidine diastereoisomers as potent functional agonists and antagonists of the human melanocortin-4 receptor.
    Chen C; Jiang W; Tran JA; Tucci FC; Fleck BA; Markison S; Wen J; Madan A; Hoare SR; Foster AC; Marinkovic D; Chen CW; Arellano M; Saunders J
    Bioorg Med Chem Lett; 2008 Jan; 18(1):129-36. PubMed ID: 18032040
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Melanocortin subtype 4 receptor agonists: structure-activity relationships about the 4-alkyl piperidine core.
    Sebhat IK; Lai Y; Barakat K; Ye Z; Tang R; Kalyani RN; Vongs A; Macneil T; Weinberg DH; Cabello MA; Maroto M; Teran A; Fong TM; Van der Ploeg LH; Patchett AA; Nargund RP
    Bioorg Med Chem Lett; 2007 Oct; 17(20):5720-3. PubMed ID: 17768046
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Discovery of orally bioavailable 1,3,4-trisubstituted 2-oxopiperazine-based melanocortin-4 receptor agonists as potential antiobesity agents.
    Tian X; Switzer AG; Derose SA; Mishra RK; Solinsky MG; Mumin RN; Ebetino FH; Jayasinghe LR; Webster ME; Colson AO; Crossdoersen D; Pinney BB; Farmer JA; Dowty ME; Obringer CM; Cruze CA; Burklow ML; Suchanek PM; Dong L; Dirr MK; Sheldon RJ; Wos JA
    J Med Chem; 2008 Oct; 51(19):6055-66. PubMed ID: 18771254
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Synthesis and structure-activity relationships of novel dipeptides and reduced dipeptides as ligands for melanocortin subtype-4 receptor.
    Shi Q; Ornstein PL; Briner K; Richardson TI; Arnold MB; Backer RT; Buckmaster JL; Canada EJ; Doecke CW; Hertel LW; Honigschmidt N; Hsiung HM; Husain S; Kuklish SL; Martinelli MJ; Mullaney JT; O'Brien TP; Reinhard MR; Rothhaar R; Shah J; Wu Z; Xie C; Zgombick JM; Fisher MJ
    Bioorg Med Chem Lett; 2006 May; 16(9):2341-6. PubMed ID: 16297618
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.